Central Nervous System Therapeutics Market By Drug Class (Anesthetics, Anticonvulsants, Antiemetics, CNS Stimulants, Pain Relievers, Antidepressant, Antipsychotics, Others), By Disease Type (Neurovascular Diseases, CNS Trauma, Neurodegenerative Disorders {Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Amyotrophic Lateral Sclerosis, Other}, Mental Health {Anxiety Disorders, Epilepsy, Mood Disorders, Psychotic Disorders, Others}, Infectious Diseases, CNS Cancer, Others), By Route of Administration (Oral, Intravenous, Transdermal, Inhalational), By End-User (Hospitals and Clinics, Home Healthcare, Rehabilitation Center, Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Dec 2024 | Report ID: MI1563 | 230 Pages


Report Coverage:

By Drug Class

  • Anesthetics
  • Anticonvulsants
  • Antiemetics
  • CNS Stimulants
  • Pain Relievers
  • Antidepressant
  • Antipsychotics
  • Others

By Disease Type  

  • Neurovascular Diseases
  • CNS Trauma
  • Neurodegenerative Disorders
    • Alzheimer’s Disease
    • Parkinson’s Disease
    • Huntington’s Disease
    • Amyotrophic Lateral Sclerosis
    • Other
  • Mental Health
    • Anxiety Disorders
    • Epilepsy
    • Mood Disorders
    • Psychotic Disorders
    • Others
  • Infectious Diseases
  • CNS Cancer
  • Others

By Route of Administration

  • Oral
  • Intravenous
  • Transdermal
  • Inhalational

BY End-User

  • Hospitals and Clinics
  • Home Healthcare
  • Rehabilitation Center
  • Research Institutes

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • Biogen Inc.
  • Eli Lilly and Company
  • Pfizer Inc.
  • Novartis AG
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • AbbVie Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A.
  • Alkermes plc
  • H. Lundbeck A/S
  • GlaxoSmithKline plc (GSK)

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.